Pura Vida Investments, LLC Cellectis S.A. Transaction History

Pura Vida Investments, LLC

  • $145 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$15.58 - $28.41 $552,108 - $1.01 Million
-35,437 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$25.99 - $30.6 $11,357 - $13,372
437 Added 1.25%
35,437 $1 Million
Q2 2018

Aug 14, 2018
BUY
$27.78 - $38.53 $972,300 - $1.35 Million
35,000 New
35,000 $990,000

Others Institutions Holding CLLS

# of Institutions
30
Shares Held
10.8M
Call Options Held
5.9K
Put Options Held
1.4K
View Full List

About Cellectis S.A.

CLLS Quotes by TradingView
  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $71M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email